AGI-16903 is a metabolite of Enasidenib ( HY-18690 ). Enasidenib is an orally available, reversible, and selective inhibitor of mutant IDH2 enzymes , with IC 50 values of 100 nM and 400 nM against IDH2 R140Q and IDH2 R172K , respectively.
Products | Products > Disease Areas > Others | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Others | Products > Signaling Pathways > Drug Metabolite
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。